This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll provide an article about the inventor Lee-Fong Yau based on the data provided.
Title: Innovator Spotlight: Lee-Fong Yau - Pioneering Cancer Treatment Technologies
Introduction: Lee-Fong Yau, a prolific inventor based in Taipa, MO, is making waves in the field of cancer treatment with his groundbreaking patents. With a keen focus on utilizing non-coding RNA molecules and antibodies targeting tumor antigens, Yau is revolutionizing the landscape of medical compositions for preventing and treating cancer.
Latest Patents: Yau's most notable patent is a medicinal composition comprising a non-coding RNA molecule and an antibody targeting a tumor antigen. This innovative invention aims to prevent and treat various types of cancer by leveraging the synergistic combination of these two elements.
Career Highlights: Currently affiliated with the Macau University of Science and Technology, Yau has established himself as a key figure in the realm of cancer research and treatment. His dedication to developing novel and effective methods for combating cancer has earned him recognition within the scientific community.
Collaborations: Yau has collaborated closely with esteemed colleagues such as Zhi-Hong Jiang and Tian-Tian Tong. Together, they have worked towards advancing the field of oncology and developing cutting-edge solutions for cancer treatment.
Conclusion: Lee-Fong Yau's pioneering work in the realm of cancer treatment technologies underscores his commitment to innovation and scientific advancement. Through his inventive spirit and collaborative efforts, Yau continues to shape the future of cancer research and treatment, offering hope to patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile